65,437 trials
Obsessive-Compulsive Disorder
Primary: Yale Brown Obsessive Compulsive Scale — 19.14; 21.24 Scores on a scale — p=<0.05
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1C (A1C) at Week 24 — -1.67; -1.83; -1.29; -1.56 Percent of glycosylated hemoglobin — p=0.087
Adult Acute Monoblastic Leukemia (M5a) · Adult Acute Monocytic Leukemia (M5b) · Adult Acute Myeloblastic Leukemia With Maturation (M2)
Primary: Dose Limiting Toxicity — 0; 1; 0; 0 participants
Attention Deficit Disorder With Hyperactivity
Primary: Change From Baseline in Korean Version of the Attention-Deficit Hyperactivity Disorder (K-ADHD) Rating Scale (K-ARS) Total Score at Week 12 — 33.37; -20.43 units on a…
Autism · Attention Deficit Hyperactivity Disorder
Primary: Change in Attention Deficit Hyperactivity Disorder Rating Scale - IV (ADHD-RS-IV) Total Score From Baseline to 8-week Follow-up Visit — 39.9; 13.8 units on a scale…
Colon Cancer · Colorectal Cancer · Rectal Cancer
Primary: Part 1: Number of Participants With Dose-limiting Toxicities — 0 participants
Diabetic Peripheral Neuropathic Pain
Primary: Change From Baseline in Average Numeric Pain Intensity Scale (NPIS) Score at Day 84 — 6.7; 6.8; 3.905; 4.260 units on a scale
Myopia
Primary: Visual Acuity Monocular — 53; 49; 49; 48 eyes
Rheumatoid Arthritis
Primary: Change in Synovitis Measured by Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) Rheumatoid Arthritis Magnetic Resonance Image Scoring System (RAMRIS)…
Cocaine Dependence
Primary: Salivary Cortisol Levels — 0.18; 0.22 mg/dl
Frontal Lobe Dementia · Frontotemporal Lobe Dementia · Semantic Dementia
Primary: Change in Neuropsychiatric Inventory (NPI) — -1.9; 0.3 units on a scale
Atopic Asthma
Primary: Baseline Percentage of Eosinophils Recovered in the BAL Prior to Segmental Allergen Challenge — 42; 19 percentage of cells
Hemorrhoids · Pregnancy
Primary: Birth-weight — 3406.9; 3487.7 grams — p=0.17
Pain
Primary: Pain Rated by Subjects — 2.3; 2.2 Units on a scale
Untreated Childhood Brain Stem Glioma
Primary: One Year Event-free Survival (EFS) — 20 percent probability